ATE61047T1 - Tetrahydrocarbazol-1-alkansaeuren. - Google Patents
Tetrahydrocarbazol-1-alkansaeuren.Info
- Publication number
- ATE61047T1 ATE61047T1 AT87300449T AT87300449T ATE61047T1 AT E61047 T1 ATE61047 T1 AT E61047T1 AT 87300449 T AT87300449 T AT 87300449T AT 87300449 T AT87300449 T AT 87300449T AT E61047 T1 ATE61047 T1 AT E61047T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrocarbazole
- alkanoic acids
- dysmenorrhea
- prostaglandin
- angina
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title abstract 2
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 abstract 1
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036600 Premature labour Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001120 cytoprotective effect Effects 0.000 abstract 1
- 208000026440 premature labor Diseases 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 208000000995 spontaneous abortion Diseases 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82172686A | 1986-01-23 | 1986-01-23 | |
| EP87300449A EP0234708B1 (de) | 1986-01-23 | 1987-01-20 | Tetrahydrocarbazol-1-alkansäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE61047T1 true ATE61047T1 (de) | 1991-03-15 |
Family
ID=25234152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87300449T ATE61047T1 (de) | 1986-01-23 | 1987-01-20 | Tetrahydrocarbazol-1-alkansaeuren. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0234708B1 (de) |
| JP (1) | JPS62223169A (de) |
| KR (1) | KR870007117A (de) |
| AT (1) | ATE61047T1 (de) |
| AU (1) | AU592615B2 (de) |
| DE (1) | DE3768097D1 (de) |
| DK (1) | DK168007B1 (de) |
| ES (1) | ES2038653T3 (de) |
| GR (1) | GR3001828T3 (de) |
| IE (1) | IE59861B1 (de) |
| IL (1) | IL81325A (de) |
| NZ (1) | NZ218999A (de) |
| PT (1) | PT84178B (de) |
| ZA (1) | ZA87468B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4808608A (en) * | 1986-01-23 | 1989-02-28 | Merck & Co., Inc. | Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use |
| US4988820A (en) * | 1986-02-21 | 1991-01-29 | Bayer Aktiengesellschaft | Cycloalkano(1,2-B) indole-sulponamides |
| AU633563B2 (en) * | 1986-02-21 | 1993-02-04 | Bayer Yakuhin, Ltd. | Cycloalkanonesulphonamides |
| US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
| ATE90076T1 (de) * | 1986-03-27 | 1993-06-15 | Merck Frosst Canada Inc | Tetrahydrocarbazole ester. |
| EP0307077A1 (de) * | 1987-07-21 | 1989-03-15 | Merck Frosst Canada Inc. | Tetrahydrocarbazole zur Verbesserung der Cyclosporintherapie |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| GB9101375D0 (en) * | 1991-01-22 | 1991-03-06 | Erba Carlo Spa | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
| HUT76923A (hu) * | 1994-07-27 | 1998-01-28 | Sankyo Company Limited | Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek |
| DE4435477A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| DE19615119A1 (de) | 1996-04-17 | 1997-10-23 | Bayer Ag | Neue Arylessigsäureamide |
| DE19615265A1 (de) * | 1996-04-18 | 1997-12-04 | Bayer Ag | Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole |
| US6410583B1 (en) * | 2000-07-25 | 2002-06-25 | Merck Frosst Canada & Co. | Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| US7067148B2 (en) | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| AR038136A1 (es) | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
| AU2004262970B2 (en) * | 2003-08-07 | 2010-03-18 | Merck Sharp & Dohme Limited | Treatment for Alzheimer's disease and related conditions |
| US7019022B2 (en) * | 2003-12-15 | 2006-03-28 | Merck Frosst Canada & Co. | Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| JP5841361B2 (ja) * | 2011-06-29 | 2016-01-13 | 壽製薬株式会社 | 三環性化合物及びそれを含有する医薬組成物 |
| CN115335046A (zh) * | 2020-03-25 | 2022-11-11 | 思研（Sri）国际顾问与咨询公司 | 脂肪氧合酶抑制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA715217B (en) * | 1970-08-20 | 1972-04-26 | Org Nv | Anti-inflammatory preparations |
| AR205331A1 (es) * | 1972-07-24 | 1976-04-30 | Hoffmann La Roche | Procedimiento para la preparacion de carbazoles |
| US4057559A (en) * | 1973-10-01 | 1977-11-08 | American Home Products Corporation | Carbazole acetic acid derivatives |
| GB1511169A (en) * | 1975-08-29 | 1978-05-17 | American Home Prod | Trycyclic acetic acid derivatives |
| US4616028A (en) * | 1985-04-22 | 1986-10-07 | American Home Products Corporation | Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use |
-
1987
- 1987-01-20 EP EP87300449A patent/EP0234708B1/de not_active Expired - Lifetime
- 1987-01-20 ES ES198787300449T patent/ES2038653T3/es not_active Expired - Lifetime
- 1987-01-20 AT AT87300449T patent/ATE61047T1/de not_active IP Right Cessation
- 1987-01-20 DE DE8787300449T patent/DE3768097D1/de not_active Expired - Lifetime
- 1987-01-20 IL IL81325A patent/IL81325A/xx unknown
- 1987-01-21 NZ NZ218999A patent/NZ218999A/en unknown
- 1987-01-22 ZA ZA87468A patent/ZA87468B/xx unknown
- 1987-01-22 IE IE16887A patent/IE59861B1/en not_active IP Right Cessation
- 1987-01-22 AU AU67908/87A patent/AU592615B2/en not_active Ceased
- 1987-01-22 PT PT84178A patent/PT84178B/pt not_active IP Right Cessation
- 1987-01-22 DK DK034287A patent/DK168007B1/da not_active IP Right Cessation
- 1987-01-23 KR KR870000535A patent/KR870007117A/ko not_active Withdrawn
- 1987-01-23 JP JP62012634A patent/JPS62223169A/ja active Pending
-
1991
- 1991-04-23 GR GR91400513T patent/GR3001828T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU592615B2 (en) | 1990-01-18 |
| IL81325A0 (en) | 1987-08-31 |
| AU6790887A (en) | 1987-07-30 |
| DK34287A (da) | 1987-07-24 |
| ES2038653T3 (es) | 1993-08-01 |
| NZ218999A (en) | 1990-12-21 |
| DE3768097D1 (de) | 1991-04-04 |
| DK34287D0 (da) | 1987-01-22 |
| ZA87468B (en) | 1987-08-26 |
| PT84178A (pt) | 1987-02-01 |
| KR870007117A (ko) | 1987-08-14 |
| JPS62223169A (ja) | 1987-10-01 |
| GR3001828T3 (en) | 1992-11-23 |
| IE59861B1 (en) | 1994-04-20 |
| EP0234708A1 (de) | 1987-09-02 |
| IL81325A (en) | 1990-11-29 |
| PT84178B (pt) | 1990-06-29 |
| IE870168L (en) | 1987-07-23 |
| DK168007B1 (da) | 1994-01-17 |
| EP0234708B1 (de) | 1991-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0300676A3 (de) | Tetrahydrocarbazol-1-alkancarbonsäuren | |
| ATE61047T1 (de) | Tetrahydrocarbazol-1-alkansaeuren. | |
| ATE73770T1 (de) | 3-hetero-substituierte n-benzyl-indole. | |
| ES2087456T3 (es) | (biciclo-hetero-arilmetoxi)indoles como inhibidores de la biosintesis de leucotrienos. | |
| FI904132A0 (fi) | (kinolin-2-ylmetoxi) indoler som inhibitorer av leukotrieners biosyntes. | |
| CA2079374A1 (en) | (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | |
| CA2047858A1 (en) | (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes | |
| DE3577912D1 (de) | Interferometrische methoden fuer die fabrikation von halbleitervorrichtungen. | |
| EP0310179A3 (de) | Tetrahydrocarbazol-Ester | |
| ATE90076T1 (de) | Tetrahydrocarbazole ester. | |
| CA2079373A1 (en) | (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | |
| CA2007786A1 (en) | Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase | |
| CA2012137A1 (en) | Dibenzoheterocyclic hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase | |
| IT8435573V0 (it) | Apparecchiatura per l'illuminazione di zone desiderate , localizzate | |
| FI861730A0 (fi) | Foerfarande foer framstaellning av 5,6-dihydroimidazo/4,5,1-j-k//1/benzazepin-2,7(1h,4h)-dion. | |
| IT8667383A1 (it) | Dispositivo di controllo dell'accensione di lampade fluorescenti, particolarmente per l'impiego a bordo di veicoli ferroviari. | |
| IT1207854B (it) | Sezionatrice per pannelli,in cui il il telaio per l'appoggio dei pannelli e' formato con travi scatolari tra loro collegabili. | |
| IT8919857A0 (it) | Attrezzo per percorrere zone innevate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |